Sembragiline in Moderate Alzheimer's Disease: Results of a Randomized, Double-Blind, Placebo-Controlled Phase II Trial (MAyflOwer RoAD).
Nave S, Doody RS, Boada M, Grimmer T, Savola JM, Delmar P, Pauly-Evers M, Nikolcheva T, Czech C, Borroni E, Ricci B, Dukart J, Mannino M, Carey T, Moran E, Gilaberte I, Muelhardt NM, Gerlach I, Santarelli L, Ostrowitzki S, Fontoura P.
Nave S, et al. Among authors: pauly evers m.
J Alzheimers Dis. 2017;58(4):1217-1228. doi: 10.3233/JAD-161309.
J Alzheimers Dis. 2017.
PMID: 28550255
Free PMC article.
Clinical Trial.